Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3106521000168111 | Bicillin L-A (benzathine benzylpenicillin 900 mg / 2.3 mL) injection, 2.3 mL syringe (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3106531000168114 | Bicillin L-A 1.2 million units (900 mg)/2.3 mL injection, 2.3 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Bicillin L-A 1.2 million units (900 mg)/2.3 mL injection, 2.3 mL syringe | has manufactured dose form | injection | false | Inferred relationship | Some | ||
Bicillin L-A 1.2 million units (900 mg)/2.3 mL injection, 2.3 mL syringe | Is a | trade product unit of use | false | Inferred relationship | Some | ||
Bicillin L-A 1.2 million units (900 mg)/2.3 mL injection, 2.3 mL syringe | Is a | Bicillin L-A | false | Inferred relationship | Some | ||
Bicillin L-A 1.2 million units (900 mg)/2.3 mL injection, 2.3 mL syringe | Is a | benzathine benzylpenicillin 1.2 million units (900 mg)/2.3 mL injection, syringe | false | Inferred relationship | Some | ||
Bicillin L-A 1.2 million units (900 mg)/2.3 mL injection, 2.3 mL syringe | has manufactured dose form | injection suspension | false | Inferred relationship | Some | ||
Bicillin L-A 1.2 million units (900 mg)/2.3 mL injection, 2.3 mL syringe | has Australian BoSS | benzathine benzylpenicillin | false | Inferred relationship | Some | 1768083244 | |
Bicillin L-A 1.2 million units (900 mg)/2.3 mL injection, 2.3 mL syringe | has intended active ingredient | benzathine benzylpenicillin | false | Inferred relationship | Some | 1768083244 | |
Bicillin L-A 1.2 million units (900 mg)/2.3 mL injection, 2.3 mL syringe | has unit of use | syringe | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Bicillin L-A 1.2 million units (900 mg)/2.3 mL injection, 5 x 2.3 mL syringes | has TPUU | False | Bicillin L-A 1.2 million units (900 mg)/2.3 mL injection, 2.3 mL syringe | Inferred relationship | Some | |
Bicillin L-A 1.2 million units (900 mg)/2.3 mL injection, 10 x 2.3 mL syringes | has TPUU | False | Bicillin L-A 1.2 million units (900 mg)/2.3 mL injection, 2.3 mL syringe | Inferred relationship | Some | |
Bicillin L-A 1.2 million units (900 mg)/2.3 mL injection, 5 x 2.3 mL syringes | has TPUU | False | Bicillin L-A 1.2 million units (900 mg)/2.3 mL injection, 2.3 mL syringe | Inferred relationship | Some | |
Bicillin L-A 1.2 million units (900 mg)/2.3 mL injection, 10 x 2.3 mL syringes | has TPUU | False | Bicillin L-A 1.2 million units (900 mg)/2.3 mL injection, 2.3 mL syringe | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set